Jenny Legac

450 total citations
21 papers, 314 citations indexed

About

Jenny Legac is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Jenny Legac has authored 21 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 10 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Jenny Legac's work include Malaria Research and Control (14 papers), HIV/AIDS drug development and treatment (6 papers) and Mosquito-borne diseases and control (4 papers). Jenny Legac is often cited by papers focused on Malaria Research and Control (14 papers), HIV/AIDS drug development and treatment (6 papers) and Mosquito-borne diseases and control (4 papers). Jenny Legac collaborates with scholars based in United States, India and South Africa. Jenny Legac's co-authors include Philip J. Rosenthal, Vipan Kumar, Bharvi Sharma, Anu Rani, Parvesh Singh, Yvonne R. Freund, Joseph L. DeRisi, Roland A. Cooper, David A. Fidock and Patrick G. Schupp and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jenny Legac

19 papers receiving 310 citations

Peers

Countries citing papers authored by Jenny Legac

Since Specialization

Citations

This map shows the geographic impact of Jenny Legac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Legac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Legac more than expected).

Fields of papers citing papers by Jenny Legac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Legac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Legac. The network helps show where Jenny Legac may publish in the future.

Co-authorship network of co-authors of Jenny Legac

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Legac. A scholar is included among the top collaborators of Jenny Legac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Legac. Jenny Legac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural optimization of indolizinoindolones to obtain potent new antimalarials with dual stage activity 2025 ·European Journal of Medicinal Chemistry Reports ·Paulo Pacheco, Ricardo Ferreira, Diana Fontinha, (unknown), Jenny Legac, (unknown), Philip J. Rosenthal, Miguel Prudêncio, Diogo Rodrigo Magalhães Moreira, Maria M. M. Santos	0
2	Synthesis and In Vivo Profiling of Desymmetrized Antimalarial Trioxolanes with Diverse Carbamate Side Chains 2024 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Jun Chen, (unknown), Ke Cheng, Priyadarshini Jaishankar, Julie Kim, Jenny Legac, Philip J. Rosenthal, Adam R. Renslo	1
3	Determination of sulfadoxine and pyrimethamine in microvolume human plasma using ultra high performance liquid chromatography-tandam mass spectrometry 2024 ·Journal of Chromatography B ·(unknown), Florence Marzan, Michelle E. Roh, Kevin Guo, Jenny Legac, Norah Mwebaza, Grant Dorsey, Philip J. Rosenthal, Francesca Aweeka, Liusheng Huang	1
4	Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso 2024 ·Antimicrobial Agents and Chemotherapy ·Anyirékun Fabrice Somé, Melissa D. Conrad, (unknown), (unknown), Rakiswendé Serge Yerbanga, (unknown), (unknown), (unknown), (unknown), Jenny Legac, (unknown), Jeffrey A. Bailey, Jean‐Bosco Ouédraogo, Philip J. Rosenthal, Roland A. Cooper	1
5	Naphthyl bearing 1,3,4-thiadiazoleacetamides targeting the parasitic folate pathway as anti-infectious agents: in silico, synthesis, and biological approach 2023 ·RSC Medicinal Chemistry ·Kavita Pal, (unknown), (unknown), (unknown), Jenny Legac, (unknown), (unknown), Nida Shahid, Sneha Singh, (unknown), (unknown), Abhik Sen, Nikhat Manzoor, Bharat C. Dixit, Robyn L. van Zyl, Philip J. Rosenthal, Nasimul Hoda	1
6	Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 2023 ·Bioorganic Chemistry ·Santo Previti, Roberta Ettari, (unknown), Jenny Legac, (unknown), (unknown), Tanja Schirmeister, Philip J. Rosenthal, Maria Zappalà	0
7	Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Diana Fontinha, Jenny Legac, Jinxin V. Pei, (unknown), Mattia Mori, Adele M. Lehane, Philip J. Rosenthal, Miguel Prudêncio, Maria M. M. Santos	16
8	Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin Analogues 2022 ·ACS Chemical Biology ·(unknown), (unknown), Christian Kersten, Maria A. Patras, Michael Kurz, (unknown), Stefan Hammerschmidt, Jenny Legac, Peter Hammann, Andreas Vilcinskas, Philip J. Rosenthal, Tanja Schirmeister, Armin Bauer, Till F. Schäberle	4
9	Identification, in-vitro anti-plasmodial assessment and docking studies of series of tetrahydrobenzothieno[2,3-d]pyrimidine-acetamide molecular hybrids as potential antimalarial agents 2022 ·European Journal of Medicinal Chemistry ·Kavita Pal, Md Kausar Raza, Jenny Legac, Abdur Rahman, Shoaib Manzoor, Souvik Bhattacharjee, Philip J. Rosenthal, Nasimul Hoda	12
10	Functionalized 3-hydroxy-3-aminoquinoline-oxindole hybrids as promising dual-function anti-plasmodials 2022 ·SHILAP Revista de lepidopterología ·Bharvi Sharma, Jenny Legac, Nosipho Cele, Paul Awolade, Philip J. Rosenthal, Parvesh Singh, Vipan Kumar	8
11	Hitting Drug-Resistant Malaria Infection With Triazole-Linked Flavonoid–Chloroquine Hybrid Compounds 2022 ·Future Medicinal Chemistry ·Francesca Seghetti, Federica Belluti, Angela Rampa, Silvia Gobbi, Jenny Legac, Silvia Parapini, Nicoletta Basilico, Alessandra Bisi	4
12	Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights 2022 ·Chemical Biology & Drug Design ·Bharvi Sharma, (unknown), Jenny Legac, Philip J. Rosenthal, Vipan Kumar	8
13	Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children 2021 ·Nature Communications ·Erika Wallender, Ali M. Ali, Emma Hughes, Abel Kakuru, Prasanna Jagannathan, Mary Muhindo, Bishop Opira, (unknown), Liusheng Huang, (unknown), Jenny Legac, Moses R. Kamya, Grant Dorsey, Francesca Aweeka, Philip J. Rosenthal, Rada Savic	11
14	A trio of quinoline-isoniazid-phthalimide with promising antiplasmodial potential: Synthesis, in-vitro evaluation and heme-polymerization inhibition studies 2021 ·Bioorganic & Medicinal Chemistry ·Anu Rani, (unknown), Jenny Legac, Philip J. Rosenthal, Parvesh Singh, Vipan Kumar	17
15	Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation 2020 ·mBio ·(unknown), Wesley Wu, Jenny Legac, (unknown), Eric E. Easom, Roland A. Cooper, Jacob J. Plattner, Yvonne R. Freund, Joseph L. DeRisi, Philip J. Rosenthal	21
16	Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights 2020 ·ACS Medicinal Chemistry Letters ·Shalini Shalini, Jenny Legac, Adebayo A. Adeniyi, (unknown), Philip J. Rosenthal, Parvesh Singh, Vipan Kumar	22
17	Substituted 1,3-dioxoisoindoline-4-aminoquinolines coupled via amide linkers: Synthesis, antiplasmodial and cytotoxic evaluation 2019 ·Bioorganic Chemistry ·Anu Rani, Jenny Legac, Philip J. Rosenthal, Vipan Kumar	16
18	Synthesis, anti-plasmodial and cytotoxic evaluation of 1H-1,2,3-triazole/acyl hydrazide integrated tetrahydro-β-carboline-4-aminoquinoline conjugates 2019 ·Bioorganic & Medicinal Chemistry Letters ·Bharvi Sharma, (unknown), Jenny Legac, Philip J. Rosenthal, Vipan Kumar	36
19	Design, Synthesis, Heme Binding and Density Functional Theory Studies of Isoindoline-Dione-4-Aminoquinolines as Potential Antiplasmodials 2019 ·Future Medicinal Chemistry ·Anu Rani, Sumit Kumar, Jenny Legac, Adebayo A. Adeniyi, Paul Awolade, Parvesh Singh, Philip J. Rosenthal, Vipan Kumar	17
20	A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue 2017 ·Nature Communications ·(unknown), Caroline L. Ng, Lee M, (unknown), (unknown), Yasheen Zhou, M.R. Alley, Vida Ahyong, Laura M. Sanz, María José Lafuente-Monasterio, (unknown), Patrick G. Schupp, Jiří Gut, Jenny Legac, Roland A. Cooper, Francisco‐Javier Gamo, Joseph L. DeRisi, Yvonne R. Freund, David A. Fidock, Philip J. Rosenthal	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact